Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Heteroaralkyl and heteroarylthioalkyl thiophenolic compounds as 5-lipoxgenase inhibitors

Heteroaralkyl and heteroarylthioalkyl thiophenolic compounds as 5-lipoxgenase inhibitors

US Patent 5635514 · Granted Jun 3, 1997

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Substituted cycloalkanes for managing nephrogenic diabetes insipidus2025
Piperidine urea derivatives as soluble epoxide hydrolase inhibitors2024
Piperidine urea derivatives as soluble epoxide hydrolase inhibitors2024
Substituted cycloalkanes for managing nephrogenic diabetes insipidus2023
Substituted cycloalkanes for managing nephrogenic diabetes insipidus2021
Substituted benzylamino quinolines as cholesterol ester-transfer protein inhibit2017
Benzylamine derivatives and their utility as cholesterol ester-transfer protein 2017
Kappa opioid receptor agonists2016
Substituted benzylamino quinolines as cholesterol ester-transfer protein inhibit2015
Methods and compositions for treatment of diabetes and dyslipidemia2014
Substituted benzylamino quinolines as cholesterol ester-transfer protein inhibit2013
Methods for the treatment of diabetes-associated dyslipdemia2011